Optimum Nutrition
1
/
of
7
NusaPure Black Cherry Extract 20:1 - Suitable for Vegetarian/Vegan, Non - GMO - 150mg 250 Capsules
NusaPure Black Cherry Extract 20:1 - Suitable for Vegetarian/Vegan, Non - GMO - 150mg 250 Capsules
No reviews
No reviews
Regular price
$24.99 USD
Regular price
Sale price
$24.99 USD
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
The full picture
Everything Vyvata knows about this product — the score, the evidence, the FAQ, and where else to find shopper reviews. No hidden data. Every vendor is scored on the same published rubric — no brand can pay for placement. Read the rubric →
44/100
Rejected
Six-dimension breakdown
Evidence
40
Formulation
42
Manufacturing
50
Safety
65
Transparency
45
Sustainability
50
Why this scored 44/100
NusaPure Black Cherry Extract is a 20:1 whole-fruit cherry extract at 150 mg per capsule. The published evidence for tart cherry (Prunus cerasus, Montmorency) — the specific variety used in trials — targets gout uric acid reduction, exercise recovery, and sleep quality using tart cherry JUICE or concentrate at 240-480 mg anthocyanin equivalent per day (Howatson 2010 for exercise recovery, Howatson 2012 for sleep, Zhang 2012 for gout). The 150 mg 20:1 extract this product delivers implies 3 g raw cherry equivalent — well below the anthocyanin loads used in trials (typically 480 mg concentrated tart cherry powder = CherryPURE dose). Additionally, black cherry (Prunus serotina) is a distinct species from Montmorency tart cherry and does not automatically share the tart cherry evidence base. The product does not specify Montmorency variety, does not standardize to anthocyanin content, and uses a sub-therapeutic dose. Rejected under sub_therapeutic_dose.
Last scored: Full rubric →
Evidence & sources
The Vyvata score's Evidence dimension measures the quality of published RCT support for a product's active ingredients at the label dose. Our source hierarchy: double-blind RCTs in MEDLINE-indexed journals > single-blind RCTs > open-label trials > observational studies > mechanism papers > N=1 case studies (anecdotes). Predatory journals and manufacturer-authored studies without independent replication are weighted down.
Product-specific evidence citations for this item are embedded in the analysis text on the "Analysis" tab. For the full framework and evidence hierarchy, see the methodology page.
How to read the Evidence dimension
- 80–100: Multiple double-blind RCTs in indexed journals directly testing this product OR the exact ingredients at the exact dose.
- 60–79: Single double-blind RCT + supporting ingredient literature at the studied dose.
- 40–59: Open-label trials + ingredient literature; no product-specific double-blind evidence.
- 20–39: Ingredient literature only; no product-specific trials or trials in predatory venues.
- 0–19: No credible evidence base or unverifiable claims.
FAQ data has not been generated for this product yet. See the site FAQ for general questions.
Customer reviews
Reviews on other platforms
The Vyvata score measures product integrity against a published rubric, not customer sentiment. Vyvata does not aggregate, republish, or license third-party reviews — the links below open search pages on their respective platforms.
All the data we have on this product
Every VSF-related metafield surfaced verbatim. Nothing hidden. If you spot data that looks wrong, let us know.
- VSF score
- 44 / 100
- Tier
- Rejected
- Category
- Supplements
- Subcategory
- joint bone connective
- Last scored
- Third-party certifications
- None on record at time of scoring
- Vendor
- NusaPure
- Tags
- NusaPure, Shopify Collective
Every score is set from the published rubric, audit-logged, and rescored whenever new evidence emerges (published trials, updated labels, third-party testing releases). Every vendor is scored on the same criteria — no pay-to-play. See our editorial-independence disclosure for the full policy, including brands with an editorial relationship to this site.
Share
